| Literature DB >> 27239407 |
Pawel Szulc1, Clément Feyt1, Roland Chapurlat1.
Abstract
BACKGROUND: Several studies assessed the association of prevalent fractures with muscle mass, strength, and physical capacity in men. Clinical impact of these associations is not clear, and they could be influenced by confounders. Our aim was to assess the association of the prevalent fractures with muscle strength, physical function, and the risk of subsequent falls in older men after adjustment for muscle mass and potential confounders.Entities:
Keywords: Fall; Fragility fracture; Men; Muscle strength; Physical performance
Year: 2015 PMID: 27239407 PMCID: PMC4864191 DOI: 10.1002/jcsm.12066
Source DB: PubMed Journal: J Cachexia Sarcopenia Muscle ISSN: 2190-5991 Impact factor: 12.910
Descriptive analysis of 890 men aged 50 and older participating in the cross‐sectional study
| Variable | Mean ± SD |
|---|---|
| Age (years) | 70 ± 9 |
| Body weight (kg) | 79 ± 11 |
| Body height (cm) | 169 ± 7 |
| BMI (kg/m2) | 27.6 ± 3.6 |
| Upper limb RASM (kg/m2) | 2.56 ± 0.32 |
| Lower limb RASM (kg/m2) | 5.71 ± 0.62 |
| Grip strength (kPa) | 71.0 ± 17.7 |
| Current smoking (n,%) | 60 (6.6) |
| Alcohol intake (g/week) | 109 [16; 234] |
| Calcium intake (mg/d) | 767 ± 248 |
| Leisure physical activity (h/week) | 3.0 [0.8; 7.0] |
| Time spent outdoors (h/week) | 7 [4; 10] |
| Occupational physical activity (n,%): Low | 203 (22.2) |
| Average | 274 (30.0) |
| High | 255 (27.9) |
| Very high | 182 (19.9) |
| Ischemic heart disease (n,%) | 132 (14.4) |
| History of myocardial infarction (n,%) | 54 (5.9) |
| Hypertension (n,%) | 351 (38.4) |
| Diabetes mellitus (n,%) | 115 (12.6) |
| History of stroke (n,%) | 33 (3.6) |
| Parkinson's disease (n,%) | 15 (1.6) |
| Abdominal aortic calcification | 1 [0; 3] |
| Physical activity score <9 (n,%) | 155 (17.4) |
| History of falls (n,%) | 179 (20.1) |
| Vertebral fractures (n,%) | 92 (10.3) |
| Non‐vertebral fractures (n,%) | 100 (11.2) |
| All fractures (n,%) | 168 (18.9) |
| Total testosterone (nmol/L) | 11.8 ± 5.3 |
| Sex hormone‐binding globulin (nmol/L) | 44.1 ± 22.3 |
| Apparent free testosterone (pmol/L) | 243 ± 93 |
| 25‐Hydroxycholecalciferol (ng/mL) | 22 ± 10 |
| C‐reactive protein (ng/mL) | 1.65 [0.83; 3.18] |
Median [first quartile, third quartile].
Association of upper limb RASM and grip strength with potential determinants in multivariable models
|
| upper limb RASM (kg/m2) | Grip strength (kPa) | Grip strength (kPa)—adjusted for upper limb RASM | |
|---|---|---|---|---|
| Current and former smoking | ||||
| Never (reference) | 289 | 2.55 ± 0.32 | 69.7 ± 17.8 | 70.1 ± 17.8 |
| ≤6 packet‐years | 135 | 2.57 ± 0.31 | 70.0 ± 16.5 | 70.2 ± 16.1 |
| >6–15 packet‐years | 148 | 2.58 ± 0.32 | 71.3 ± 19.6 | 71.4 ± 19.2 |
| >15–28 packet‐years | 146 | 2.59 ± 0.34 | 73.8 ± 17.1 | 73.4 ± 17.1 |
| >28 packet‐years | 172 | 2.54 ± 0.32 | 72.4 ± 17.4 | 72.8 ± 17.4 |
| Alcohol drinking | ||||
| ≤1 unit/wk | 239 | 2.53 ± 0.34 | 69.3 ± 17.2 | 70.0 ± 17.0 |
| >1–7 units/wk | 241 | 2.57 ± 0.33 | 72.4 ± 18.1 | 72.4 ± 18.1 |
| >7–14 units/wk (ref.) | 168 | 2.61 ± 0.32 | 71.5 ± 16.9 | 70.9 ± 16.9 |
| >14 units/wk | 242 | 2.55 ± 0.30 | 71.8 ± 18.1 | 72.2 ± 17.8 |
| Leisure physical activity (h/week) | ||||
| <1 h/wk | 240 | 2.53 ± 0.32 | 68.4 ± 16.9 | 69.1 ± 16.5 |
| 1–3 h/wk | 245 | 2.55 ± 0.34 | 72.3 ± 17.9 | 72.7 ± 17.9 |
| >3–7 h/wk | 185 | 2.57 ± 0.28 | 72.7 ± 16.5 | 72.8 ± 16.9 |
| >7 h/wk (reference) | 220 | 2.61 ± 0.33 | 71.6 ± 17.7 | 71.2 ± 17.8 |
| Occupational physical activity | ||||
| Light (reference) | 199 | 2.54 ± 0.30 | 73.1 ± 17.5 | 73.7 ± 17.4 |
| Moderate | 274 | 2.55 ± 0.30 | 72.2 ± 16.6 | 72.5 ± 16.5 |
| Heavy | 242 | 2.57 ± 0.35 | 70.5 ± 18.0 | 70.4 ± 18.1 |
| Very heavy | 175 | 2.59 ± 0.34 | 68.5 ± 17.4 | 68.5 ± 17.2 |
| History of myocardial infarction | ||||
| Yes | 47 | 2.54 ± 0.32 | 67.1 ± 15.8 | 67.7 ± 14.9 |
| No (reference) | 843 | 2.56 ± 0.32 | 71.4 ± 17.7 | 71.6 ± 17.7 |
| Hypertension | ||||
| Yes | 333 | 2.58 ± 0.32 | 70.9 ± 16.4 | 71.0 ± 16.1 |
| No (reference) | 557 | 2.55 ± 0.32 | 71.6 ± 18.3 | 71.9 ± 18.3 |
| Type 2 diabetes mellitus | ||||
| Yes | 112 | 2.56 ± 0.32 | 67.8 ± 17.0 | 68.2 ± 16.5 |
| No (reference) | 778 | 2.56 ± 0.32 | 71.7 ± 17.5 | 71.9 ± 17.5 |
| History of stroke | ||||
| Yes | 32 | 2.56 ± 0.32 | 68.7 ± 13.3 | 68.8 ± 13.0 |
| No (reference) | 858 | 2.56 ± 0.32 | 71.4 ± 18.7 | 71.6 ± 17.8 |
| Parkinson's disease | ||||
| Yes | 14 | 2.51 ± 0.36 | 61.5 ± 12.2 | 62.2 ± 12.2 |
| No (reference) | 876 | 2.56 ± 0.32 | 71.5 ± 17.8 | 71.7 ± 17.7 |
| C‐reactive protein (CRP) | ||||
| <1 ng/mL (reference) | 282 | 2.60 ± 0.31 | 72.7 ± 18.2 | 72.4 ± 18.2 |
| 1 – <3 ng/mL | 378 | 2.57 ± 0.32 | 71.9 ± 17.3 | 72.0 ± 17.3 |
| 3 – <5 ng/mL | 101 | 2.51 ± 0.33 | 68.8 ± 16.7 | 69.8 ± 16.6 |
| ≥5 ng/mL | 129 | 2.51 ± 0.33 | 68.7 ± 17.5 | 69.8 ± 17.1 |
| Apparent free testosterone concentration (AFTC) | ||||
| <192 pmol/L | 223 | 2.51 ± 0.36 | 70.0 ± 17.4 | 71.0 ± 17.2 |
| 192 – <243 pmol/L | 222 | 2.57 ± 0.31 | 71.6 ± 18.1 | 71.5 ± 18.1 |
| 243 – <297 pmol/L | 225 | 2.56 ± 0.29 | 72.0 ± 16.4 | 72.2 ± 16.4 |
| ≥297 pmol/L (reference) | 220 | 2.60 ± 0.33 | 71.8 ± 18.5 | 71.5 ± 18.4 |
| 25‐Hydroxycholecalciferol (25OHD) | ||||
| <15 ng/mL | 201 | 2.48 ± 0.34 | 69.3 ± 17.2 | 70.7 ± 16.8 |
| 15 – <21 ng/mL | 239 | 2.55 ± 0.32 | 71.5 ± 18.1 | 71.6 ± 18.1 |
| 21 – <28 ng/mL | 219 | 2.58 ± 0.33 | 70.8 ± 17.6 | 70.7 ± 17.6 |
| ≥28 ng/mL (reference) | 231 | 2.62 ± 0.29 | 73.5 ± 17.5 | 73.0 ± 17.5 |
| Vertebral fracture | ||||
| Yes | 92 | 2.56 ± 0.33 | 67.2 ± 16.9 | 67.7 ± 16.6 |
| No (reference) | 798 | 2.56 ± 0.29 | 71.7 ± 17.6 | 71.8 ± 17.5 |
| Vertebral fracture severity | ||||
| Grade 2 and 3 | 76 | 2.56 ± 0.33 | 66.6 ± 17.2 | 67.1 ± 16.8 |
| Grade 1 | 16 | 2.59 ± 0.21 | 70.7 ± 13.7 | 70.3 ± 14.2 |
| No (reference) | 798 | 2.56 ± 0.30 | 71.7 ± 17.6 | 71.8 ± 17.5 |
| Non‐vertebral fractures | ||||
| Yes | 100 | 2.56 ± 0.28 | 68.4 ± 16.9 | 69.2 ± 16.5 |
| No (reference) | 790 | 0.52 ± 0.33 | 71.5 ± 17.8 | 71.8 ± 17.9 |
| All fractures (vertebral and non‐vertebral jointly) | ||||
| >1 fracture | 61 | 2.56 ± 0.31 | 67.2 ± 17.2 | 67.7 ± 16.5 |
| 1 fracture | 106 | 2.53 ± 0.27 | 68.9 ± 15.9 | 69.5 ± 15.8 |
| No (reference) | 723 | 2.56 ± 0.33 | 71.9 ± 17.8 | 72.0 ± 17.7 |
The analyses were performed using the analysis of covariance. The covariables in the models include age, body mass index (both continuous), smoking, alcohol intake, occupational and leisure physical activity, hypertension, diabetes mellitus, Parkinson's disease, prior stroke, prior myocardial infarction, AFTC, 25OHD, and CRP. Unless otherwise stated, the variables were introduced in the models as described in the Table.
p < 0.05;
p < 0.01;
p < 0.005;
p < 0.001—vs. the reference group using the post hoc Dunnett–Hsu test.
Figure 1A) Prevalence of poor physical function (defined as the lowest quintile of the score of physical function) according to the age. B) Incidence of multiple falls according to the age (the incidence was calculated using time to the first fall in men with multiple falls).
Association of poor physical function (defined as score <9) with potential determinants in the multivariable model—all the variables were introduced simultaneously in the model
| Variable | OR (95%CI)—without adjustment for lower limb RASM | OR (95%CI)—with adjustment for lower limb RASM |
|---|---|---|
| Lower limb RASM <5.28 kg/m2 | — | 2.05 (1.03 – 4.04) |
| 5.28 – <5.66 kg/m2 | — | 1.78 (0.90 – 3.51) |
| 5.66 – <6.11 kg/m2 | — | 2.04 (1.02 – 4.08) |
| ≥6.11 kg/m2 | — | 1.00 |
| Age (year) | 1.13 (1.10 – 1.17) | 1.12 (1.09 – 1.16) |
| Current smoking—yes vs. no | 2.21 (0.94 – 5.19) | 2.22 (0.94 – 5.26) |
| Alcohol drinking—≤1 unit/wk | 2.21 (1.14 – 4.26) | 2.22 (1.14 – 4.30) |
| >1 – 7 units/wk | 2.26 (1.14 – 4.45) | 2.15 (1.07 – 4.29) |
| >7 – 14 units/wk | 1.00 | 1.00 |
| >14 units/wk | 1.50 (0.76 – 2.97) | 1.42 (0.71 – 2.84) |
| Leisure physical activity—<1 vs ≥1 h/wk | 3.56 (2.28 – 5.58) | 3.67 (2.33 – 5.77) |
| Occupational physical activity—Light | 1.00 | 1.00 |
| Moderate | 1.01 (0.51 – 2.01) | 1.01 (0.51 – 2.02) |
| High | 1.16 (0.59 – 2.26) | 1.14 (0.58 – 2.24) |
| Very high | 2.09 (1.06 – 4.14) | 2.06 (1.04 – 4.10) |
| Diabetes mellitus—yes vs. no | 2.68 (1.52 – 4.71) | 2.79 (1.57 – 4.96) |
| History of stroke—yes vs. no | 3.69 (1.42 – 9.61) | 3.52 (1.33 – 9.30) |
| Apparent free testosterone—<192 pmol/L | 2.48 (1.23 – 5.01) | 2.66 (1.31 – 5.41) |
| 192 – <243 pmol/L | 1.45 (0.69 – 3.05) | 1.46 (0.69 – 3.07) |
| 243 – <297 pmol/L | 2.66 (1.30 – 5.44) | 2.62 (1.28 – 5.39) |
| ≥297 pmol/L | 1.00 | 1.00 |
| 25‐Hydroxycholecalciferol—<15 ng/ml | 2.18 (1.19 – 3.99) | 2.15 (1.15 – 4.27) |
| 15 – <21 ng/mL | 1.12 (0.59 – 2.10) | 1.12 (0.59 – 2.11) |
| 21 – <28 ng/mL | 0.70 (0.34 – 1.43) | 0.74 (0.36 – 1.53) |
| ≥28 ng/mL | 1.00 | 1.00 |
| C‐reactive protein—<1 ng/mL | 1.00 | 1.00 |
| 1 – <3 ng/mL | 1.00 (0.57 – 1.74) | 1.04 (0.60 – 1.82) |
| 3 – <5 ng/mL | 0.97 (0.44 – 2.16) | 1.02 (0.46 – 2.27) |
| ≥5 ng/mL | 2.26 (1.18 – 4.33) | 2.22 (1.15 – 4.27) |
| Abdominal aortic calcification (unit) | 1.07 (0.93 – 1.16) | 1.06 (0.92 – 1.13) |
| Vertebral fracture—yes vs. no | 2.53 (1.19 – 2.02) | 2.59 (1.40 – 4.80) |
p < 0.05;
p < 0.01;
p < 0.005;
p < 0.001.
Association of poor physical function with the prior fractures in multivariable models adjusted for the confounders presented in Table 3
| Variable |
| OR (95%CI)—without adjustment for lower limb RASM | OR (95%CI)—with adjustment for lower limb RASM |
|---|---|---|---|
| Vertebral fracture—yes vs. no | 2.45 (1.34 – 4.48) | 2.59 (1.41 – 4.76) | |
| Vertebral fracture severity—none | 798 | 1.00 | 1.00 |
| Grade 1 | 17 | 1.98 (0.47 – 8.35) | 2.17 (0.49 – 9.58) |
| Grade 2 | 56 | 2.12 (1.01 – 4.44) | 2.28 (1.08 – 4.82) |
| Grade 3 | 19 | 4.24 (1.38 – 13.0) | 4.04 (1.31 – 12.5) |
| Non‐vertebral fractures—yes vs no | 2.36 (1.27 – 4.38) | 2.28 (1.22 – 4.25) | |
| Non‐vertebral fractures—0 | 790 | 1.00 | 1.00 |
| 1 | 84 | 1.81 (0.90 – 3.63) | 1.76 (0.87 – 3.54) |
| >1 | 16 | 7.56 (2.13 – 26.9) | 7.05 (1.96 – 25.3) |
| All fractures—yes vs. no | 2.56 (1.55 – 4.24) | 2.57 (1.55 – 4.27) | |
| Number of all fractures—none | 723 | 1.00 | 1.00 |
| 1 | 106 | 1.91 (1.03 – 3.54) | 1.92 (1.03 – 3.58) |
| >1 | 61 | 3.99 (1.97 – 8.09) | 3.96 (1.95 – 8.05) |
Both models are adjusted for age, current smoking, alcohol drinking, leisure and occupational physical activity, diabetes mellitus, prior stroke, apparent free testosterone concentration, 25‐hydroxycholecalciferol, C‐reactive protein, and abdominal aortic calcification.
p < 0.05;
p < 0.01;
p < 0.005;
p < 0.001;
p for trend;
p < 0.005
p < 0.001.
Association with vertebral and non‐vertebral fractures at baseline with the risk of multiple falls assessed prospectively over 5 years
|
| Multivariable model HR (95%CI) | + as above and lower limb RASM HR (95%CI) | |
|---|---|---|---|
| Vertebral fracture: 2 and 3 vs. 0 and 1 | 2.22 (1.37 – 3.60) | 2.22 (1.37 – 3.61) | |
| Vertebral fracture—none | 723 | 1.00 | 1.00 |
| 1 | 54 | 1.59 (0.86 – 2.94) | 1.59 (0.86 – 2.94) |
| >1 | 36 | 2.73 (1.39 – 5.35) | 2.73 (1.39 – 5.36) |
| Vertebral fracture severity—none | 723 | 1.00 | 1.00 |
| Grade 1 | 16 | 0.52 (0.07 – 3.77) | 0.53 (0.07 – 3.84) |
| Grade 2 | 57 | 2.16 (1.27 – 3.66) | 2.16 (1.27 – 3.66) |
| Grade 3 | 17 | 2.39 (0.85 – 6.71) | 2.39 (0.85 – 6.72) |
| Non‐spine fractures: yes vs. no | 1.36 (0.81 – 2.27) | 1.36 (0.81 – 2.28) | |
| Non‐spine fractures: none | 715 | 1.00 | 1.00 |
| 1 | 83 | 1.19 (0.67 – 2.12) | 1.19 (0.67 – 2.13) |
| >1 | 15 | 2.62 (0.94 – 7.27) | 2.67 (0.96 – 7.46) |
| All fractures: yes vs. no | 1.74 (1.17 – 2.59) | 1.74 (1.17 – 2.59) | |
| All fractures: none | 651 | 1.00 | 1.00 |
| 1 | 104 | 1.45 (0.89 – 2.36) | 1.45 (0.89 – 2.37) |
| >1 | 58 | 2.61 (1.48 – 4.61) | 2.61 (1.48 – 4.61) |
p < 0.05;
p < 0.01;
p < 0.005;
p < 0.001;
p for trend;
p < 0.05;
p < 0.005
Multivariable model—adjusted for age, height, current smoking, time spent outdoors, calcium intake, prior myocardial infarction, prior stroke, diabetes mellitus, Parkinson's disease, abdominal aortic calcification, AFTC, and C‐reactive protein.